TheEdgeResearch
Home / Stocks / MBGNF

Many Bright Ideas Technologies Inc. (MBGNF)

OTC Healthcare Medical - Diagnostics & Research
$0.01 ▲ +0.00%
Market Cap
$101,821
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.57
52-Wk Range
0.0059-0.01
CEO
Iain Weir-Jones
Country
CA
Currency
USD

Many Bright Ideas Technologies Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $101,821. On trailing twelve-month figures it carries a trailing P/E of -2.19, a net margin of 0.0%. Its beta of 1.57 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.19
Price / Sales
0.00
Price / Book
-0.44
EV / EBITDA
-6.39
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.83
Current ratio
0.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7
IPO date
2018-08-24
Headquarters
Vancouver, BC, CA
About Many Bright Ideas Technologies Inc.

Many Bright Ideas Technologies Inc. (MBGNF) currently operates with minimal business activity. This Vancouver-based company, founded in 2006, adopted its current name in June 2022, having previously been known as Med BioGene Inc. Historically, its focus was within the life sciences sector, specifically dedicated to developing and bringing to market genomic diagnostic solutions for non-small-cell lung cancer. Although its operations are currently limited, the company's stated strategic objective is to commercialize various technologies across a range of industrial sectors.

Comparable companies

Many Bright Ideas Technologies Inc. is most often compared with the following Healthcare names:

ACMSYCHOOFCRVWEVRRFGTHPHSITFIMMVFIZOZFNVLPFUEEC
More research on MBGNF
MBGNF technical analysis MBGNF TheEdge Score Compare against peers
Open full interactive analysis & DCF →